Franz Eberli

Franz Eberli

Auto-generated profile, based on publicly available information

Franz Eberli

Department of Cardiology, Triemli Hospital, Zurich, Switzerland (G.F., F.E.).

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in EuroIntervention
Verified
Journal Article
Open access
Scot GargScot Garg
Scot Garg
JWJoanna Wykrzykowska
Joanna Wykrzykowska
PSPatrick Serruys
Patrick Serruys
TVTon de Vries
Ton de Vries
Paweł BuszmanPaweł Buszman
Paweł Buszman
SWStephan Windecker
Stephan Windecker
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

1 December 2020 in European Heart Journal: Acute Cardiovascular Care
Verified
Journal Article
Open access
PDF file
MMMatthias R Meyer
Matthias R Meyer
DRDragana Radovanovic
Dragana Radovanovic
GPGiovanni Pedrazzini
Giovanni Pedrazzini
HRHans Rickli
Hans Rickli
MRMarco Roffi
Marco Roffi
DKDavid J Kurz
David J Kurz
In patients with acute myocardial infarction, the presence of a left bundle branch block or right bundle branch block may be associated with worse prognosis compared to isolated ST segment elevation. However, specificities in clinical presentation and outcomes of acute myocardial infarction patients with left bundle branch block or right bundle branch block are poorly characterized. We analysed acute myocardial infarction patients with left bundle branch block (n=880), right bundle branch block (n=732) or ST segment elevation without bundle branch block (n=15,852) included in the Acute Myocardial Infarction in Switzerland-Plus registry between 2008–2019. Acute myocardial infarction patients with bundle branch block were older and had more pre-existing cardiovascular conditions compared to ST segment elevation. Pulmonary oedema and cardiogenic shock were most frequent in patients with left bundle branch block (18.8% vs 12.0% for right bundle branch block and 7.9% for ST segment elevation, p<0.001). Acute myocardial infarction patients with bundle branch block had more three-vessel (40.6% vs 25.3%, p<0.001 vs ST segment elevation) and left main disease (5.6% vs 2.0%, p<0.001 vs ST segment elevation). Major adverse cardiac and cerebrovascular events, a composite of reinfarction, stroke/transient ischaemic attack, and death during hospitalization, were highest in acute myocardial infarction patients with left bundle branch block (13.9% vs 9.9% for right bundle branch block and 6.7% for ST segment elevation, p<0.05), which was driven by hospital mortality. After multivariate adjustment, however, mortality was similar in patients with left bundle branch block and lower in patients with right bundle branch block, respectively, when compared to ST segment elevation. Mortality was only increased when a right bundle branch block with concomitant STE was present (odds ratio 1.77, 95% confidence interval 1.19–2.64, p<0.01 vs ST segment elevation). Compared to ST segment elevation, an isolated bundle branch block reflects high-risk clinical characteristics but does not independently determine increased hospital mortality in acute myocardial infarction.

13 December 2022 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
PDF file
FFFabienne Foster-Witassek
Fabienne Foster-Witassek
HRHans Rickli
Hans Rickli
MRMarco Roffi
Marco Roffi
GPGiovanni Pedrazzini
Giovanni Pedrazzini
FEFranz Eberli
Franz Eberli
DRDragana Radovanovic
Dragana Radovanovic
Aims: This study aimed to analyse changes in pre-hospital delay over time in women and men presenting with ST-elevation myocardial infarction (STEMI) in Switzerland. Methods and results: AMIS Plus registry data of patients admitted for STEMI between 2002 and 2019 were analysed using multivariable quantile regression including the following covariates: interaction between sex and admission year, age, diabetes, pain at presentation, myocardial infarction (MI) history, heart failure history, hypertension, and renal disease. Among the 15,350 patients included (74.5% men), the median (interquartile range) delay between 2002 and 2019 was 150 (84; 345) min for men and 180 (100; 414) min for women. The unadjusted median pre-hospital delay significantly decreased over time for both sexes but the decreasing trend was stronger for women. Specifically, the unadjusted sex differences in delay decreased from 60 min in 2002 (P = 0.0042) to 40.5 min in 2019 (P = 0.165). The multivariable model revealed a significant interaction between sex and admission year (P = 0.038) indicating that the decrease in delay was stronger for women (−3.3 min per year) than for men (−1.6 min per year) even after adjustment. The adjusted difference between men and women decreased from 26.93 min in 2002 to −1.97 min for women in 2019. Conclusion: Over two decades, delay between symptom onset and hospital admission in STEMI decreased significantly for men and women. The decline was more pronounced in women, leading to the sex gap disappearing in the adjusted analysis for 2019.

13 January 2011 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
TBTimm Bauer
Timm Bauer
HMHelge Mollmann
Helge Mollmann
FWFranz Weidinger
Franz Weidinger
UZUwe Zeymer
Uwe Zeymer
RSRicardo Seabra‐Gomes
Ricardo Seabra‐Gomes
AGAnselm K. Gitt
Anselm K. Gitt

9 July 2021 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
FEFranz R. Eberli
Franz R. Eberli
HSHans‐Peter Stoll
Hans‐Peter Stoll
PUPhilip Urban
Philip Urban
MMMarie‐Claude Morice
Marie‐Claude Morice
PBPhilippe Brunel
Philippe Brunel
PGPhilippe Garot
Philippe Garot
Background: In patients at high bleeding risk (HBR), the LEADERS FREE (LF) trial established the safety and efficacy of a polymer‐free drug coated (Biolimus‐A9) stainless steel stent (SS‐DCS) with 30 days of dual antiplatelet treatment (DAPT). In LEADERS FREE III, we studied a new cobalt‐chromium thin‐strut stent (CoCr‐DCS) in HBR patients.Methods: The CoCr‐DCS shares all of the design features of the SS‐DCS but has a CoCr stent platform with strut thickness of 84–88 μm. The primary safety endpoint was a composite of cardiac death, myocardial infarction (MI), and definite/probable stent thrombosis. The primary efficacy endpoint was clinically indicated target lesion revascularization. Outcomes were compared to those of LF (non‐inferiority to SS‐DCS for safety and superiority to SS‐BMS for efficacy). Additional propensity‐matched comparisons were performed to account for baseline differences.Results: We recruited 401 HBR patients using identical criteria to the LF trial. At 1 year, the primary safety endpoint was reached by 31/401 (8.0%) of patients treated with the CoCr‐DCS versus 35/401 (8.9%) for the propensity‐matched cohort (HR: 0.89, [0.55–1.44], p < 0.001 for non‐inferiority, 0.62 for superiority). The efficacy endpoint was reached by 16/401 (4.2%) of CoCr‐DCS patients versus 41/401 (10.6%) in the propensity‐matched cohort (HR: 0.4 [0.2:0.7]) (p = 0.007 for superiority). There was no statistical difference between CoCr‐DCS and SS‐DCS in terms of efficacy (HR: 1.46 [0.68–3.15], p = 0.33).Conclusions: The new thin‐strut CoCr‐DCS proved non‐inferior to the SS‐DCS for safety, and superior to the BMS for efficacy in HBR patients treated with 30 days of DAPT.

1 October 2006 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
PDF file
YNYvonne Nussbaumer-Ochsner
Yvonne Nussbaumer-Ochsner
FEFranz R. Eberli
Franz R. Eberli
RBRalf W. Baumgartner
Ralf W. Baumgartner
KLKlara Landau
Klara Landau
MRMarco Roffi
Marco Roffi
Purpose: To present a patient in whom severe external carotid artery (ECA) stenosis causing ocular ischemia was treated with a drug-eluting stent. Case Report: A 55-year-old woman with severe, diffuse atherosclerosis presented with impaired left ocular perfusion and amaurosis fugax. Duplex ultrasonography and angiography documented bilateral occlusion at the origin of the internal carotid arteries, bilateral subtotal ECA stenoses, and subtotal distal left common carotid artery (CCA) restenosis following endarterectomy. Percutaneous revascularization of the left ECA and CCA stenoses was performed using a short coronary balloon-expandable sirolimus-eluting stent and a self-expanding nitinol stent, respectively. The procedure was uneventful, and the ocular symptoms resolved. At 6 months, the patient remained asymptomatic, with angiographically patent stents. Conclusion: Drug-eluting stenting may be a novel option to treat symptomatic ECA stenosis.